Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Saved in:
| Title: | Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. |
|---|---|
| Authors: | Li R; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Roger.Li@moffitt.org.; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Roger.Li@moffitt.org., Shah PH; Department of Urology, Mayo Clinic, Rochester, MN, USA., Stewart TF; Department of Medicine, UC San Diego, La Jolla, CA, USA., Nam JK; Pusan National University, Yangsan Hospital, Yangsan, South Korea., Bivalacqua TJ; Department of Urology, University of Pennsylvania, Philadelphia, PA, USA., Lamm DL; BCG Oncology, Phoenix, AZ, USA., Uchio EM; Department of Urology, UC Irvine, Irvine, CA, USA., Geynisman DM; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Jacob JM; Department of Urology, SUNY Medical Center, Upstate, Syracuse, NY, USA., Meeks JJ; Department of Urology, Northwestern University Medical Center, Chicago, IL, USA., Dickstein R; Chesapeake Urology, Hanover, MD, USA., Pearce SM; Spokane Urology, Spokane, WA, USA., Kang SH; Korea University, Anam Hospital, Seoul, South Korea., Jung SI; Chonnam National University, Hwasun Hospital, Bundang, South Korea., Kamat AM; Department of Urology, UT MD Anderson Cancer Center, Houston, TX, USA., Burke JM; Billings Clinic, Billings, MT, USA., Keegan KA; CG Oncology, Irvine, CA, USA.; Department of Urology, Vanderbilt University, Nashville, TN, USA., Steinberg GD; Department of Urology, Rush University Medical Center, Chicago, IL, USA. |
| Source: | Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2372. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38890533 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+R%22">Li R</searchLink>; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Roger.Li@moffitt.org.; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Roger.Li@moffitt.org.<br /><searchLink fieldCode="AU" term="%22Shah+PH%22">Shah PH</searchLink>; Department of Urology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+TF%22">Stewart TF</searchLink>; Department of Medicine, UC San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nam+JK%22">Nam JK</searchLink>; Pusan National University, Yangsan Hospital, Yangsan, South Korea.<br /><searchLink fieldCode="AU" term="%22Bivalacqua+TJ%22">Bivalacqua TJ</searchLink>; Department of Urology, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lamm+DL%22">Lamm DL</searchLink>; BCG Oncology, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Uchio+EM%22">Uchio EM</searchLink>; Department of Urology, UC Irvine, Irvine, CA, USA.<br /><searchLink fieldCode="AU" term="%22Geynisman+DM%22">Geynisman DM</searchLink>; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Jacob+JM%22">Jacob JM</searchLink>; Department of Urology, SUNY Medical Center, Upstate, Syracuse, NY, USA.<br /><searchLink fieldCode="AU" term="%22Meeks+JJ%22">Meeks JJ</searchLink>; Department of Urology, Northwestern University Medical Center, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Dickstein+R%22">Dickstein R</searchLink>; Chesapeake Urology, Hanover, MD, USA.<br /><searchLink fieldCode="AU" term="%22Pearce+SM%22">Pearce SM</searchLink>; Spokane Urology, Spokane, WA, USA.<br /><searchLink fieldCode="AU" term="%22Kang+SH%22">Kang SH</searchLink>; Korea University, Anam Hospital, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Jung+SI%22">Jung SI</searchLink>; Chonnam National University, Hwasun Hospital, Bundang, South Korea.<br /><searchLink fieldCode="AU" term="%22Kamat+AM%22">Kamat AM</searchLink>; Department of Urology, UT MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Burke+JM%22">Burke JM</searchLink>; Billings Clinic, Billings, MT, USA.<br /><searchLink fieldCode="AU" term="%22Keegan+KA%22">Keegan KA</searchLink>; CG Oncology, Irvine, CA, USA.; Department of Urology, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Steinberg+GD%22">Steinberg GD</searchLink>; Department of Urology, Rush University Medical Center, Chicago, IL, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2372. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38890533 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-024-03137-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2372 Titles: – TitleFull: Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li R – PersonEntity: Name: NameFull: Shah PH – PersonEntity: Name: NameFull: Stewart TF – PersonEntity: Name: NameFull: Nam JK – PersonEntity: Name: NameFull: Bivalacqua TJ – PersonEntity: Name: NameFull: Lamm DL – PersonEntity: Name: NameFull: Uchio EM – PersonEntity: Name: NameFull: Geynisman DM – PersonEntity: Name: NameFull: Jacob JM – PersonEntity: Name: NameFull: Meeks JJ – PersonEntity: Name: NameFull: Dickstein R – PersonEntity: Name: NameFull: Pearce SM – PersonEntity: Name: NameFull: Kang SH – PersonEntity: Name: NameFull: Jung SI – PersonEntity: Name: NameFull: Kamat AM – PersonEntity: Name: NameFull: Burke JM – PersonEntity: Name: NameFull: Keegan KA – PersonEntity: Name: NameFull: Steinberg GD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 30 – Type: issue Value: 8 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |